Form 6-K RedHill Biopharma Ltd. For: Jul 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Redhill Biopharma (RDHL) PT Raised to $28 at Nomura/Instinet
July 30, 2018 1:00 PM EDTNomura/Instinet raised its price target on Redhill Biopharma (NASDAQ: RDHL) to $28.00 (from $18.00) while maintaining a Buy rating following positive RHB-104 results.
Analyst Christopher Marai note management indicated that a 16-week time-point measure is a reasonable endpoint, but they will await... More
